根据Dictamni皮质的抗牛皮病药动力学材料基础 基于通过皮的成分组组
Zhaoyu Wang1,2, Mengting Pi1,2, Ziang Gao1,2,3
1State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Beijing 100700, China.
Pharmaceutics
|September 27, 2025
概括
迪卡姆尼皮层 (DC) 含有通过皮肤的化合物,通过抑制炎症和细胞增殖,有效治疗牛皮. 迪克塔米尼显示出理想的抗牛皮疗效,支持DC.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 传统中国医药 传统中国医药
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病,通常用局部药物治疗.
- 目前的牛皮治疗方法面临的局限性包括不良反应,耐药性和成本.
- 迪卡姆尼皮层 (DC) 具有用于牛皮的局部使用的历史,其治疗基础是通过皮肤的成分.
研究的目的:
- 为了在Dictamni Cortex (DC) 的通过皮肤组成部分中识别抗牛皮的活性成分.
- 调查DC局部抗牛皮作用的药理机制.
- 为开发用于治疗牛皮的局部DC制剂提供科学基础.
主要方法:
- 综合超高性能液态色谱四极飞行时间质谱 (UPLC-Q-TOF-MS) 和网络药理学.
- 描述了DC的化学成分,并确定了通过皮肤透的化合物.
- 在类似牛皮的HaCaT细胞模型中验证了关键化合物的抗牛皮活性.
主要成果:
- 在DC中确定了26种通过皮肤透的化合物,主要是化物和化物.
- 网络药理学发现MMP9和TLR4是参与炎症和免疫反应的核心点.
- 关键化合物,包括迪克塔明因,抑制细胞增殖,降低基67的调节,减少促炎细胞因子 (IL-17A,IL-22,IL-1β,IL-6,IL-8).
结论:
- 迪克坦尼在体外显示出显著的抗牛皮疗效.
- 该研究建立了用于治疗牛皮的局部DC制剂的药理基础.
- 提供了对传统中医药局部药物的药学动力学物质基础的新见解.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
437
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
437
01:29Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521
01:29Therapeutic Drug Monitoring: Affecting Factors
201
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
201
01:22Drug Delivery: Miscellaneous Routes
713
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
713
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
179
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
179